E-ISSN 0976-2833 | ISSN 0975-3583
 

Original Research (Original Article) 


IL – 8 Serum Level Estimation in the Iraqi Myloproliferative Neoplasm Patients with and without JAK2-V617F Mutation

Ahmed Rushdi Abdullah.

Abstract
Introduction: Myeloproliferative neoplasm (MPN) is a long-term blood disease that has an excess production of mature hematopoietic pluripotent stem cells (HPSC) in the bone marrow. The Iraqi cancer registry announced that Chronic Myeloproliferative disorders in male has 0.62% incidence rate and 0.36, in female Chronic Myeloproliferative disorders 45case 0.31% and incidence rate 0.24. The JAK2-V617F mutation is approximately 70% presented in the myeloproliferative neoplasm cases. This is a somatic mutation that concern changing of the amino acid valine to phenylalanine at codon region 617 (that’s why it’s called JAK2-V617F) presented in the pseudo kinase domain. JAK2-V617F mutation is 50% to 70% in Essential Thrombocythemia (ET), 40% to 50% in Primary Myelofibrosis (PMF), and 95% in Polycythemia Vera (PV). IL-8 elevated level in MPNs has a major part in the presence of symptoms.

Materials and Methods: Total of (60) patients screened by cohort prospective study of having MPN who are patients presented to the National Center of Hematology / AlMustansiriyah university, Depending on JAK2-V617F mutation we classified the patients into 3 groups: JAK2-V617F positive (N: 40), JAK2-V617F negative (N: 20) and control group. Blood sample (5) ml was obtained from each individual in each group, by venipuncture using disposable syringes for IL-8 serum estimation.

Results: A clear indication of significant differences is seen between IL-8 serum level in JAK2-V617F negative group and control group (P < 0.05). Also, a significant difference occurred among IL-8 serum level in JAK2-V617F positive samples and IL-8 serum level of JAK2-V617F negative samples.

Conclusion: IL-8 serum level in all MPN patients is high as a part of chronic inflammation, But, IL-8 serum level of JAK2-V617F negative group is higher than the JAK2-V617F positive group due to many reasons like the source of IL8 is not related to the JAK2-V617F mutation.

Key words: Interleukin 8 serum level, MPN, JAK2-V617F negative, JAK2-V617F positive.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Ahmed Rushdi Abdullah
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Ahmed Rushdi Abdullah. IL – 8 Serum Level Estimation in the Iraqi Myloproliferative Neoplasm Patients with and without JAK2-V617F Mutation. . 2020; 11(3): 106-110. doi:10.31838/jcdr.2020.11.03.25


Web Style

Ahmed Rushdi Abdullah. IL – 8 Serum Level Estimation in the Iraqi Myloproliferative Neoplasm Patients with and without JAK2-V617F Mutation. http://www.jcdronline.org//?mno=119691 [Access: August 03, 2020]. doi:10.31838/jcdr.2020.11.03.25


AMA (American Medical Association) Style

Ahmed Rushdi Abdullah. IL – 8 Serum Level Estimation in the Iraqi Myloproliferative Neoplasm Patients with and without JAK2-V617F Mutation. . 2020; 11(3): 106-110. doi:10.31838/jcdr.2020.11.03.25



Vancouver/ICMJE Style

Ahmed Rushdi Abdullah. IL – 8 Serum Level Estimation in the Iraqi Myloproliferative Neoplasm Patients with and without JAK2-V617F Mutation. . (2020), [cited August 03, 2020]; 11(3): 106-110. doi:10.31838/jcdr.2020.11.03.25



Harvard Style

Ahmed Rushdi Abdullah (2020) IL – 8 Serum Level Estimation in the Iraqi Myloproliferative Neoplasm Patients with and without JAK2-V617F Mutation. , 11 (3), 106-110. doi:10.31838/jcdr.2020.11.03.25



Turabian Style

Ahmed Rushdi Abdullah. 2020. IL – 8 Serum Level Estimation in the Iraqi Myloproliferative Neoplasm Patients with and without JAK2-V617F Mutation. Journal of Cardiovascular Disease Research, 11 (3), 106-110. doi:10.31838/jcdr.2020.11.03.25



Chicago Style

Ahmed Rushdi Abdullah. "IL – 8 Serum Level Estimation in the Iraqi Myloproliferative Neoplasm Patients with and without JAK2-V617F Mutation." Journal of Cardiovascular Disease Research 11 (2020), 106-110. doi:10.31838/jcdr.2020.11.03.25



MLA (The Modern Language Association) Style

Ahmed Rushdi Abdullah. "IL – 8 Serum Level Estimation in the Iraqi Myloproliferative Neoplasm Patients with and without JAK2-V617F Mutation." Journal of Cardiovascular Disease Research 11.3 (2020), 106-110. Print. doi:10.31838/jcdr.2020.11.03.25



APA (American Psychological Association) Style

Ahmed Rushdi Abdullah (2020) IL – 8 Serum Level Estimation in the Iraqi Myloproliferative Neoplasm Patients with and without JAK2-V617F Mutation. Journal of Cardiovascular Disease Research, 11 (3), 106-110. doi:10.31838/jcdr.2020.11.03.25





Most Viewed Articles
  • Reduced nitrate level in individuals with hypertension and diabetes
    Shiekh Gazalla Ayub, Taha Ayub, Saquib Naveed Khan, Rubiya Dar, Khurshid Iqbal Andrabi
    . 2011; 2(3): 172-176
    » Abstract » doi: 10.4103/0975-3583.85264

  • Association of statin therapy with blood pressure control in hypertensive hypercholesterolemic outpatients in clinical practice
    Manuel Morgado, Sandra Rolo, Ana Filipa Macedo, Miguel Castelo-Branco
    . 2011; 2(1): 44-49
    » Abstract » doi: 10.4103/0975-3583.78596

  • Abdominal obesity, an independent cardiovascular risk factor in Indian subcontinent: A clinico epidemiological evidence summary
    D. S. Prasad, Zubair Kabir , A. K. Dash, B. C. Das
    . 2011; 2(4): 199-205
    » Abstract » doi: 10.4103/0975-3583.89803

  • Utilization of Real-time 3D Transesophageal Echocardiography in an Urban Academic Medical Center
    Lili Zhang, Elaine Y. Lin, Dron Bhandari, Mohan Pamerla, George K. Lui, Cynthia C. Taub
    . 2014; 5(2): 9-14
    » Abstract » doi: 10.5530/jcdr.2014.2.3

  • High prevalence of cardiovascular diseases among other medically compromised conditions in dental patients: A retrospective study
    Sumit Bhateja
    . 2012; 3(2): 113-116
    » Abstract » doi: 10.4103/0975-3583.95364

  • Most Downloaded
  • Review Article: Impact of Ivabradine on Cardiovascular Morbidity
    Gammone M, Riccioni G, D’Orazio
    . 2020; 11(1): 4-8
    » Abstract » doi: 10.5530/jcdr.2020.11.02

  • Vascular Endothelial Growth Factor and its Soluble Receptor-1 as Surrogate Markers for Subjects with High-risk of Cardiovascular Disease
    Vipa Boonkitticharoen, Chanika Sritara, Prin Vathesatogkit, Supakajee Saengruang-Orn,Wipa Ratanachaiwong, Piyamitr Sritara
    . 2014; 5(2): 35-42
    » Abstract » doi: 10.5530/jcdr.2014.2.8

  • Study of Metabolic Syndrome and Its Components Among Kurnool District Population of Andhra Pradesh with Different Ethnic Backgrounds
    Pandit Vinodh Bandela, Nilima Nandakumar Dongre, Jeevan Gangadhar Ambekar, Kedam Durga Prasad, Basavaraj B Devaranavadagi
    . 2017; 8(3): 83-88
    » Abstract » doi: 10.5530jcdr.2017.3.20

  • Diagnosis and surgical treatment of carotid body tumor: A report of 18 cases
    Dan Ma, Min Liu, Hua Yang, Xiaogan Ma, Chaojun Zhang
    . 2010; 1(3): 122-124
    » Abstract » doi: 10.4103/0975-3583.70905

  • P2Y receptors as regulators of lung endothelial barrier integrity
    Evgeny Zemskov, Rudolf Lucas Alexander D. Verin, Nagavedi S. Umapathy
    . 2011; 2(1): 14-22
    » Abstract » doi: 10.4103/0975-3583.78582

  • Most Cited Articles